Mole Removal / Naevus Excision | Mole Removal in Different Age Groups

Most moles are harmless, and new moles commonly appear in children and teenagers. Removal is considered for aesthetic concerns, mechanical irritation, or suspicion of malignancy. If melanoma cannot be ruled out, surgical removal with histology is appropriate. When suspicion is not strong, delaying excision may be advisable because children have a higher risk of postsurgical keloids. A strong family history of melanoma may support earlier removal of suspicious moles. Larger congenital nevi, especially nodular areas, may be excised because of melanoma risk; giant or large hairy congenital nevi may be removed prophylactically in infancy or early childhood. Children may develop new moles, and harmless ones are usually observed rather than treated.

Most moles are harmless, and new moles often appear in children and teenagers. Removal may be considered for appearance, irritation or concern about cancer. A mole that has grown should be removed completely to lower recurrence and false melanoma risk; suspicious changes need removal with lab testing. For very large birth moles, early removal may be done in newborns up to two months under general anaesthesia. Childhood melanoma is treated much like adult melanoma, often with a one-centimetre margin. The doctor can discuss benefits, limitations and timing for your child. Age, cooperation, size, site and depth also guide the plan with you.

There are no absolute contraindications for mole-removal techniques, but the procedure is deferred for active infection or uncontrolled diabetes. The method depends on the mole’s type, size, location and anticipated depth. An acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma risk. Any suspicion of dysplastic change warrants excision biopsy with histopathological assessment. Shave excision and punch techniques are contraindicated when malignancy is suspected, and radiofrequency is contraindicated with cardiac disease, pacemakers or metallic prosthesis. Complications are uncommon when surgical principles are followed, but keloidal tendency, sun exposure, darker skin types and poor wound healing can affect late outcomes.

Congenital melanocytic nevi are present at birth and occur in about 2–3% of newborns. Small lesions may be monitored, while larger or hairy nevi carry higher concern for malignant change; one source estimates a 6–12% lifetime risk for large nevi. Because malignant change usually does not occur before adolescence, removal before adolescence is considered when feasible. In babies, excision may require general anaesthesia, so its risks must be weighed against the mole’s risk. Some lesions cannot be removed without causing greater deformity and may need staged excision. Prophylactic excision of giant and large hairy nevi is indicated in infancy and early childhood. Laser is not recommended for congenital nevi because complete removal of deep cells is not assured.

Small and medium congenital moles carry a low lifetime melanoma risk, and melanoma in them usually occurs after puberty, so routine prophylactic removal is not generally recommended. Decisions are individualized by location, monitoring ability, family history, irritation and scarring risk. Larger congenital nevi, especially nodular areas, have higher transformation risk and may need excision. If melanoma cannot be excluded, surgical removal with histology is appropriate. For small or medium lesions, expected scar must be balanced against benefit; removal before puberty may be considered for irritation, poor visibility or cosmetic concern, while larger lesions may need staged procedures and anesthesia risk must be weighed carefully in consultation.

Method depends on the mole’s type, size, location and anticipated depth. An acquired melanocytic nevus should be removed completely to reduce recurrence and pseudomelanoma formation. Blood tests usually rule out diabetes and bleeding disorders; extensive preoperative workup is usually not required. Active infection or uncontrolled diabetes may defer treatment. Radiofrequency is contraindicated with cardiac disease, pacemakers or metallic prostheses, and shave or punch excision is contraindicated when malignancy is suspected. Late complications often relate to keloidal tendency, sun exposure, skin type or poor wound healing, so patient selection matters. Minimal damage to surrounding normal skin and an aesthetically acceptable scar are also surgical goals.

Aging skin changes in older adults, such as slower epidermal turnover, reduced vascularity, collagen, fibroblasts and macrophages, can delay wound healing after mole removal and may increase infection risk in some surgical contexts. However, evidence is not uniform: one study found no significant association between age and drainage duration or volume, while a plastic surgery review found aging may temporarily delay healing without impairing final scar quality, and elderly patients may have improved scar appearance. Mole removal method depends on type, size, location and anticipated depth, with complete removal and minimal surrounding damage as guiding principles. Individual healing also depends on diabetes control, nutrition and skin type.

The source lists no absolute contraindications for any mole-removal technique, but procedures are deferred for active infection or uncontrolled diabetes. Other contraindications include keloidal tendency and bleeding disorders. Radiofrequency is contraindicated with cardiac disease, pacemakers or metallic prostheses, while shave excision and punch techniques are contraindicated when malignancy is suspected. The method depends on the mole's type, size, location and anticipated depth. Late complications can relate to keloidal tendency, excessive sun exposure, Fitzpatrick type 4 or 5 skin and poor wound healing; dyschromia is common in Fitzpatrick types 3 to 5, and erythema is common in fairer Indian skin types 1 or 2.

Diabetes can slow wound healing and raise infection risk, and surgical stress can make glucose control harder. That is why blood tests may check for diabetes before mole surgery. Uncontrolled diabetes is a contraindication, while controlled diabetes may allow treatment with careful planning. There are no absolute contraindications for any technique, but active infection or uncontrolled diabetes means deferring. The method depends on mole type, size, location and depth, and any suspicious change needs proper assessment before removal. Good glucose control and clinician review help decide safe timing. Diabetic patients may need individualized perioperative glucose monitoring and wound-care follow-up. Healing expectations should be discussed with your clinician before the procedure.